ALLO vs CCI · rev $22.0K vs P/E 40, rev $6.57B
Allogene Therapeutics Inc (ALLO) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
ALLO currently screens at market cap $258.1M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the ALLO and CCI stock pages for the full models.
Not investment advice.